Hepcludex® (bulevirtide‑gmod)
| Full Name | Hepcludex® (bulevirtide‑gmod) |
| Drug | bulevirtide |
| Manufacturer | Gilead Sciences, Inc. |
| Route of Administration | Subcutaneous |
| Site of Care | Home |
| Approved Indication | The treatment of chronic hepatitis delta (HDV) infection in adults without cirrhosis or with compensated cirrhosis |
| Disease | Chronic hepatitis delta (HDV) infection |
| Therapeutic Area | Hepatology |
| Phone Number | 847-457-4259 |
| Fax Number | 877-860-2504 |
| Enrollment Form Link | Enrollment Form |
| Product Website | hepcludexhcp.com |